$0.99
+0.00 (+0.00%)
Market Cap
$12.4M
Shares Outstanding
11,832,834
Institutional Holders
2
Total Inst. Value
$70K
% of Float Held
—
QoQ Holder Change
—
Institutional data as of Q1 2025
New Positions
1
Closed Positions
1
Increased
1
Decreased
0
Institutional Ownership Trend
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | CITADEL ADVISORS LLCNew | $39K | 17,250 |
| 2 | UBS Group AG | $31K | 14,447 |
Biggest Buyers & Sellers This Quarter
Top Buyers
| Fund | Shares Added | Value |
|---|---|---|
| CITADEL ADVISORS LLCNew | +17K | $39K |
| UBS Group AG | +4K | $31K |
Top Sellers
| Fund | Shares Removed | Value |
|---|
Related Stocks
Frequently Asked Questions
How many institutional investors hold GDTC?
As of Q1 2025, 2 institutional investors report holding GDTC (CytoMed Therapeutics Limited) in their 13F filings.
Which hedge fund owns the most GDTC?
The largest institutional holder of GDTC is CITADEL ADVISORS LLC with $39K in shares.
Are institutions buying or selling GDTC?
This quarter, 1 institutions opened new positions in GDTC and 1 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.